Embryomic

Embryomic is advancing IVF outcomes through metabolomic diagnostics backed by rigorous science. Our flagship test, PMT-BC™, has been validated through extensive research, including a five-part preprint series outlining the clinical, scientific, and translational foundations of our technology. These publications highlight the robust evidence supporting metabolomics as a breakthrough tool in embryo selection and reproductive health. By combining cutting-edge research with state-of-the-art laboratory infrastructure at DCU Alpha Innovation Campus, Dublin, we deliver solutions that improve success rates, shorten time to pregnancy, and transform fertility care worldwide.